Search the MBS

Standard Search

Advanced Search Search Tips

Enter keywords or item numbers below
Search Options

Results 1 to 10 of 40 matches

Category 5 - DIAGNOSTIC IMAGING SERVICES

Capital Sensitivity Diagnostic Imaging Equipment

Category 5 - DIAGNOSTIC IMAGING SERVICES

Requests for R-type Diagnostic Imaging Services

Category 5 - DIAGNOSTIC IMAGING SERVICES

Group I2 - Computed Tomography (CT)

Category 5 - DIAGNOSTIC IMAGING SERVICES

Category 5 - DIAGNOSTIC IMAGING SERVICES

Substitute PET items for use in radiopharmaceutical supply disruptions

Category 3 - THERAPEUTIC PROCEDURES

Definition of ‘disease progression’ for the continuation of 177Lutetium PSMA therapy (MBS Item 16055)

Category 3 - THERAPEUTIC PROCEDURES

16050

16050 - Additional Information

Item Start Date:
01-Jul-2025
Description Updated:
01-Jul-2025
Schedule Fee Updated:
01-Jul-2025

Group
T3 - Therapeutic Nuclear Medicine
Subgroup
2 - Theranostics

Administration of Lutetium 177 PSMA, followed within 36 hours by whole body Lu-PSMA SPECT, for treatment of a patient with metastatic castrate resistant prostate cancer who is:

(a) PSMA-positive as determined by PSMA PET (defined as SUVmax >15 at a single site of disease and SUVmax >10 at all sites of measurable disease) after disease progression and

(b) prior treatment includes at least one taxane chemotherapy and at least one androgen receptor signalling inhibitor.

Applicable once per cycle, up to a maximum of 2 cycles in the initial treatment phase.



Fee: $8,000.00 Benefit: 75% = $6,000.00 85% = $7,897.60

Category 5 - DIAGNOSTIC IMAGING SERVICES

61333

61333 - Additional Information

Item Start Date:
14-Sep-2019
Description Updated:
01-Nov-2022
Schedule Fee Updated:
14-Sep-2019

Group
I4 - Nuclear Medicine Imaging
Subgroup
2 - PET

 

Lung ventilation study using Galligas and lung perfusion study using gallium-68 macro aggregated albumin (68Ga-MAA), with PET, if the service is performed because the service to which item 61348 applies cannot be performed due to unavailability of technetium-99m (R)

Bulk bill incentive



Fee: $443.35 Benefit: 75% = $332.55 85% = $376.85

(See para IN.4.4 of explanatory notes to this Category)

Category 5 - DIAGNOSTIC IMAGING SERVICES

61336

61336 - Additional Information

Item Start Date:
14-Sep-2019
Description Updated:
01-Nov-2022
Schedule Fee Updated:
14-Sep-2019

Group
I4 - Nuclear Medicine Imaging
Subgroup
2 - PET

Cerebral study, with PET, if the service is performed because the service to which item 61402 applies cannot be performed due to unavailability of technetium-99m (R)

Bulk bill incentive



Fee: $605.05 Benefit: 75% = $453.80 85% = $514.30

(See para IN.4.4 of explanatory notes to this Category)

Category 5 - DIAGNOSTIC IMAGING SERVICES

61341

61341 - Additional Information

Item Start Date:
14-Sep-2019
Description Updated:
01-Nov-2022
Schedule Fee Updated:
14-Sep-2019

Group
I4 - Nuclear Medicine Imaging
Subgroup
2 - PET

Bone study – whole body with PET, with delayed imaging when undertaken, if the service is performed because the services to which item 61421 or 61425 apply cannot be performed due to unavailability of technetium-99m (R)

Bulk bill incentive



Fee: $600.70 Benefit: 75% = $450.55 85% = $510.60

(See para IN.4.4 of explanatory notes to this Category)

Results 1 to 10 of 40 matches


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change